Form 8-K - Current report:
SEC Accession No. 0001683168-24-000377
Filing Date
2024-01-23
Accepted
2024-01-23 09:53:59
Documents
14
Period of Report
2024-01-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT acon_8k.htm   iXBRL 8-K 39200
2 FORM OF EXCHANGE AGREEMENT acon_ex1001.htm EX-10.1 116112
  Complete submission text file 0001683168-24-000377.txt   400610

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE acon-20240122.xsd EX-101.SCH 3788
4 XBRL DEFINITION FILE acon-20240122_def.xml EX-101.DEF 26648
5 XBRL LABEL FILE acon-20240122_lab.xml EX-101.LAB 36765
6 XBRL PRESENTATION FILE acon-20240122_pre.xml EX-101.PRE 25272
8 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5290
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 24550728
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)